Insider Trading Alert - NEWT, PTLA And RLGY Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 25, 2014, 127 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $158.00 to $38,255,692.50.

Highlighted Stocks Traded by Insiders:

Newtek Business Services (NEWT) - FREE Research Report

Mulia Salvatore Francis, who is Director at Newtek Business Services, bought 1,000 shares at $14.00 on Nov. 25, 2014. Following this transaction, the Director owned 39,445 shares meaning that the stake was boosted by 2.6% with the 1,000-share transaction.

The shares most recently traded at $14.39, up $0.39, or 2.71% since the insider transaction. Historical insider transactions for Newtek Business Services go as follows:

  • 4-Week # shares bought: 3,000
  • 4-Week # shares sold: 48
  • 12-Week # shares bought: 6,000
  • 12-Week # shares sold: 48
  • 24-Week # shares bought: 27,450
  • 24-Week # shares sold: 48

The average volume for Newtek Business Services has been 11,300 shares per day over the past 30 days. Newtek Business Services has a market cap of $107.8 million and is part of the services sector and diversified services industry. Shares are down 9.24% year-to-date as of the close of trading on Friday.

Newtek Business Services, Inc. provides financial and business services to the small-and medium-sized business market in the United States and internationally. The company has a P/E ratio of 15.9.

Exclusive Offer: Get the latest Stock Analysis on NEWT - FREE

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Portola Pharmaceuticals (PTLA) - FREE Research Report

Dier Mardi, who is Executive VP and CFO at Portola Pharmaceuticals, sold 1,118 shares at $28.23 on Nov. 25, 2014. Following this transaction, the Executive VP and CFO owned 0 shares meaning that the stake was reduced by 100% with the 1,118-share transaction.

The shares most recently traded at $28.73, up $0.50, or 1.74% since the insider transaction. Historical insider transactions for Portola Pharmaceuticals go as follows:

  • 4-Week # shares bought: 1.6 million
  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 1.6 million
  • 12-Week # shares sold: 5,000
  • 24-Week # shares bought: 1.6 million
  • 24-Week # shares sold: 18,706

The average volume for Portola Pharmaceuticals has been 379,400 shares per day over the past 30 days. Portola Pharmaceuticals has a market cap of $1.4 billion and is part of the health care sector and drugs industry. Shares are up 10.14% year-to-date as of the close of trading on Tuesday.

Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops product candidates in the fields of thrombosis and hematology. Currently, there are 2 analysts who rate Portola Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PTLA - FREE

TheStreet Quant Ratings rates Portola Pharmaceuticals as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income and weak operating cash flow. Get the full Portola Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Realogy Holdings (RLGY) - FREE Research Report

Weaving David J, who is EVP and Chief Admin. Officer at Realogy Holdings, sold 5,000 shares at $45.77 on Nov. 25, 2014. Following this transaction, the EVP and Chief Admin. Officer owned 32,783 shares meaning that the stake was reduced by 13.23% with the 5,000-share transaction.

The shares most recently traded at $45.79, up $0.02, or 0.04% since the insider transaction. Historical insider transactions for Realogy Holdings go as follows:

  • 4-Week # shares sold: 61,837
  • 12-Week # shares sold: 61,837
  • 24-Week # shares sold: 62,587

The average volume for Realogy Holdings has been 1.7 million shares per day over the past 30 days. Realogy Holdings has a market cap of $6.8 billion and is part of the financial sector and real estate industry. Shares are down 6.43% year-to-date as of the close of trading on Tuesday.

Realogy Holdings Corp. provides real estate and relocation services worldwide. The company has a P/E ratio of 15.5. Currently, there are 9 analysts who rate Realogy Holdings a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on RLGY - FREE

TheStreet Quant Ratings rates Realogy Holdings as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, generally disappointing historical performance in the stock itself, weak operating cash flow, poor profit margins and feeble growth in its earnings per share. Get the full Realogy Holdings Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Video: Jim Cramer on Rising Interest Rates, Trade Worries & Caterpillar

Video: Jim Cramer on Rising Interest Rates, Trade Worries & Caterpillar

Stocks Trade Lower as 10-Year Yield Hits 3%

Stocks Trade Lower as 10-Year Yield Hits 3%

Apple Suppliers Slide After European, Asian Chipmakers Echo Smartphone Concerns

Apple Suppliers Slide After European, Asian Chipmakers Echo Smartphone Concerns